Literature DB >> 1173561

Placental transmission of thyroid-stimulating immunoglobulins.

S M Dirmikis, D S Munro.   

Abstract

Long-acting thyroid stimulator (LATS) and LATS protector (LATS-P) were assayed at or near delivery in serum from 18 pregnant women with a history of past or present thyrotoxicosis. The results suggested that neonatal thyrotoxicosis may be predicted prenatally if maternal serum LATS and LATS-P concentrations near delivery are above certain levels.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1173561      PMCID： PMC1673547          DOI： 10.1136/bmj.2.5972.665

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  7 in total

1.  Proceedings: Studies on long-acting thyroid stimulator protector in serum containing long-acting thyroid stimulator.

Authors:  S Dirmikis; D S Munro
Journal:  J Endocrinol       Date:  1975-03       Impact factor: 4.286

2.  Letter: Neonatal hyperthyroidism and long-acting thyroid stimulator protector.

Authors:  J A Thomson; D S Dirmikis; D S Munro; B R Smith; R Hall; E D Mukhtar
Journal:  Br Med J       Date:  1975-04-05

3.  Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.

Authors:  D D Adams; T H Kennedy
Journal:  J Clin Endocrinol Metab       Date:  1967-02       Impact factor: 5.958

4.  The interaction of the long-acting thyroid stimulator (LATS) with thyroid tissue in vitro.

Authors:  B R Smith
Journal:  J Endocrinol       Date:  1970-01       Impact factor: 4.286

5.  Some factors affecting the detection of long-acting thyroid stimulator protector using the McKenzie bioassay.

Authors:  S Dirmikis
Journal:  J Endocrinol       Date:  1974-12       Impact factor: 4.286

6.  Letter: Placental transmission of L. A. T. S. protector.

Authors:  S M Dirmikis; D S Munro; E J Hiller; M J Crawford; J Wynne; M Purcell
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

7.  Neonatal thyrotoxicosis associated with maternal hypothyroidism.

Authors:  J A Thomson; I D Riley
Journal:  Lancet       Date:  1966-03-19       Impact factor: 79.321
  7 in total
  10 in total

1.  Attempted prevention of neonatal thyrotoxicosis.

Authors:  I Ramsay
Journal:  Br Med J       Date:  1976-11-06

2.  Thyroid disease in pregnancy.

Authors:  P E Belchetz
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-31

Review 3.  Pathogenesis of neonatal Graves' disease.

Authors:  J M McKenzie; M Zakarija
Journal:  J Endocrinol Invest       Date:  1978-04       Impact factor: 4.256

4.  Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.

Authors:  A Knight; D D Adams
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

5.  Prenatal treatment of fetal thyrotoxicosis.

Authors:  P L Robinson; N M O'Mullane; B Alderman
Journal:  Br Med J       Date:  1979-02-10

Review 6.  Management of endocrine disorders in pregnancy Part I--thyroid and parathyroid disease.

Authors:  Z M van der Spuy; H S Jacobs
Journal:  Postgrad Med J       Date:  1984-04       Impact factor: 2.401

Review 7.  The thyrotrophin receptor.

Authors:  S W Manley; A Knight; D D Adams
Journal:  Springer Semin Immunopathol       Date:  1982

8.  Thyroid-stimulating immunoglobulins in neonatal Graves's disease.

Authors:  C S Teng; T C Tong; J H Hutchison; R T Yeung
Journal:  Arch Dis Child       Date:  1980-11       Impact factor: 3.791

9.  Neonatal thyrotoxicosis is associated with transplacental passage of human thyroid stimulating immunoglobulin (HTSI).

Authors:  I Mitchell; G Shenfield; J Brash
Journal:  Arch Dis Child       Date:  1976-07       Impact factor: 3.791

10.  Hyperemesis gravidarum due to thyrotoxicosis.

Authors:  B H Valentine; C Jones; A J Tyack
Journal:  Postgrad Med J       Date:  1980-10       Impact factor: 2.401
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.